{"id":"W4383553191","doi":"10.3390/curroncol30070474","title":"Antibody–Drug Conjugates in Breast Cancer: Ascent to Destiny and Beyond—A 2023 Review","year":2023,"lang":"en","type":"review","venue":"Current Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Trastuzumab emtansine; Breast cancer; Trastuzumab; Cancer; Antibody-drug conjugate; Metastatic breast cancer; Clinical trial; Drug; Oncology; Internal medicine; Pharmacology; Immunology; Antibody; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004945905,0.0007768647,0.001009687,0.002076794,0.0002658797,0.001051319,0.0006574083,0.001158492,0.00500701],"category_scores_gemma":[0.0006882994,0.0002802024,0.0004965824,0.002262036,0.0003881856,0.001595121,0.0006237883,0.001725579,0.002638617],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006756468,"about_ca_system_score_gemma":0.001163631,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009955913,"about_ca_topic_score_gemma":0.001813653,"domain_scores_codex":[0.9998271,0.0000357125,0.00002090051,0.00002742508,0.0000687967,0.00002016083],"domain_scores_gemma":[0.9997311,0.0001234867,0.00003336018,0.000008130743,0.0000777559,0.000026138],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005845959,0.00007707297,0.0001200451,0.01773395,0.00006654239,0.0001617771,0.00007555068,0.0003903412,0.001438867,0.006134532,0.05894447,0.9147984],"study_design_scores_gemma":[0.000009128501,0.00006087394,0.000250608,0.003207653,0.00004785711,0.0006259148,0.00003422364,0.00006287335,0.0002037835,0.001348913,0.9941386,0.000009515505],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008185639,0.9979663,0.0000921223,0.0003619497,0.0003229389,0.000005474787,0.00001400184,0.000006241001,0.001149177],"genre_scores_gemma":[0.000362743,0.9984496,0.0001175248,0.0002637029,0.0001640042,0.000005224924,0.00002044997,0.000001416351,0.0006153997],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00500701,"threshold_uncertainty_score":0.0167501,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2938468114277656,"score_gpt":0.5896260345667751,"score_spread":0.2957792231390095,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}